期刊文献+

倾向性评分匹配法评价冠心病支架置入术后再狭窄 被引量:3

Assessment of in-stent restenosis with coronary heart disease following coronary stent implantation base on propensity score matching method
暂未订购
导出
摘要 目的 引入倾向性评分匹配法(PSM)比较伴糖尿病的冠心病患者与单纯冠心病患者支架置入术后再狭窄的差异。方法 回顾性分析在本院接受冠状动脉支架植入术患者资料, 伴糖尿病的冠心病患者137例(CHD+DM组), 单纯冠心病283例(CHD组)。使用SPSS软件的PSM功能对两组采用1:1最邻近匹配法, 得到组间协变量均衡的样本。匹配后的样本采用Cox比例风险模型评估支架术后再狭窄的危险因素。结果 两组匹配成功各120例。Cox比例风险模型多因素分析, 吸烟史(HR=2.50, 95%CI:1.34-4.64, P=0.004)、高血压史(HR=2.24, 95%CI:1.08-4.63, P=0.030)、肌酐清除率〈110 ml/min(HR=3.12, 95%CI:1.22-5.03, P=0.024)、冠状动脉多支病变(HR=2.15, 95%CI:1.14-4.07, P=0.018)和伴糖尿病(HR=2.22, 95%CI:1.14-4.33, P=0.020)是冠心病支架术后再狭窄的独立危险因素。PSM后, CHD+DM组1、3、5年的累计狭窄率分别为10.70%, 40.30%和43.80%, CHD组为4.70%, 23.70%和29.60%, 差异有统计学意义(P=0.023)。结论 应用PSM可以有效地均衡非随机研究组间的协变量, 糖尿病是冠心病患者支架置入术再狭窄的危险因素。 Objective To compare the difference in in-stent restenosis (ISR) between the coronary heart disease (CHD) with diabetes mellitus (DM) and simplex CHD following coronary stent implantation through the introduction of propensity score matching (PSM). Methods The analysis was based on a retrospectively data on patients who underwent coronary stent implantation patients. Among them, CHD with DM (CHD+DM group) patients were 137 cases, simplex CHD (CHD group) patients were 283 cases. The two groups covariate were balanced based on the PSM function of SPSS software using 1:1 nearest neighbor matching method. The Cox Proportional hazards models were applied to identify the independent risk factors for ISR after PSM. Results One hundred and twenty pairs of patients were successfully matched. Cox proportional hazard model by multivariate analysis found that history of smoking (HR=2.50, 95%CI: 1.34—4.64, P=0.004), history of hypertension (HR=2.24, 95%CI: 1.08—4.63, P=0.030), creatinine clearance rate〈110 ml/min (HR=3.12, 95%CI: 1.22—5.03, P=0.024), multiple lesions of coronary artery (HR=2.15, 95%CI: 1.14—4.07, P=0.018), and DM (HR=2.22, 95%CI: 1.14—4.33, P=0.020) were independent risk factors for ISR in CHD patients. The 1, 3, and 5 years cumulative ISR rates were 10.70%, 40.30% and 43.80% in the CHD+DM group, and 4.70%, 23.70% and 29.60% in the CHD group, respectively. There were statistically significant differences between the two groups (P=0.023). Conclusion The application of PSM can effectively balanced the covariates of groups in non-randomised study, DM is a risk factor for ISR for the CHD patients following coronary stent implantation.
出处 《中国介入影像与治疗学》 CSCD 北大核心 2015年第4期218-222,共5页 Chinese Journal of Interventional Imaging and Therapy
关键词 冠状动脉疾病 糖尿病 支架再狭窄 倾向性评分匹配 Coronary disease Diabetes mellitus In-stent restenosis Propensity score matching
  • 相关文献

参考文献15

  • 1Kirtane AJ, Ellis SG, Dawkins KD, et al. Paclitaxel-eluting coronary stents in patients with diabetes mellitus: Pooled analysis from 5 randomized trials. J Am Coll Cardiol,2008,51(7):708-715.
  • 2Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography. Heart, 2014,100(2):153-159.
  • 3Hoffmann R, Stellbrink E, Schr?der J, et al. Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents. Am J Cardiol, 2007,100(9):1347-1352.
  • 4Thoemmes F. Propensity score matching in SPSS 2010. [2014-01-29]. http://sourceforge.net/projects/psmspss/files/.
  • 5Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika, 1983,70(1):41-55.
  • 6Hansen B, Bowers J. Covariate balance in simple, stratified and clustered comparative studies. Statistical Science,2008,2(23):219-236.
  • 7Roffi M, Topol EJ. Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J, 2004,25:190-198.
  • 8陈劲松,陈韵岱,田峰,韩运峰,荆晶,刘杰,王晶,周珊珊.冠心病合并糖尿病患者药物洗脱支架置入后2年支架内再狭窄的预测因素[J].中华心血管病杂志,2014,42(1):14-18. 被引量:15
  • 9乔岩,马长生,聂绍平,刘小慧,杜昕,康俊萍,吕强,贾长琪,张崟.药物洗脱支架与金属裸支架置入术后对糖尿病患者远期死亡、心肌梗死和支架血栓发生情况的影响[J].首都医科大学学报,2012,33(4):437-445. 被引量:7
  • 10Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation, 2003,108(22):2769-2775.

二级参考文献54

  • 1Wilson SR, Vakili BA, Sherman W, et al. Effect of diabetes on long- term mortality following contemporary percutaneous coronary intervention: analysis of 4,284 cases. Diabetes Care,2004,27 : 1137-1142.
  • 2Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol, 2002, 40:410-417.
  • 3Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting stents and bare metal stents : a collaborative net work meta-analysis. Lancet, 2007,370 : 937 -948.
  • 4Shuchman MS. Tradig restenosis for thrombosis? New questions about durg-eluting stents. N Engl J Med ,2006,335 : 1949-1952.
  • 5Moreno R, Fernandez C, Hemandez R, et al. Drug-eluting stent thrombosis:Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol,2005 ,45 :954-959.
  • 6Cutlip DE, Windecker S, Mehran R, et al. On behalf of the academic research consortium. Clinical end points in coronary stent trials:a case for standardized definitions. Circulation ,2007,115:2344-2351.
  • 7Elezi S, Kastrati A, Pache J, et al. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol, 1998,32 : 1866-1873.
  • 8Ortolani P, Balducelli M, Marzaroli P, et al. Two-year clinical outcomes with drug-elutiug stents for diabetic patient with De Novo Coronary lesions:results from a real-world multicenter registry. Circulation,2008, 119:923-930.
  • 9Stettler C, Allemann S, Wandel S, et al. Drug eluting and bare metal stents in people with and without diabetes:collaborative network meta- analysis. BMJ,2008,337 : a1331.
  • 10Garg P, Normand SL, Silbaugh TS, et al. Drug-eluting of Bare-metal stenting in patients with diabetes mellitus : results from the Massachu- setts data analysis center registry. Circulation ,2008,118 (22) :2277- 2285.

共引文献32

同被引文献53

  • 1霍勇,范芳芳.关注真正的临床实践,探索卒中的预防之道——H型高血压的真实世界研究[J].中国医学前沿杂志(电子版),2013,5(2):6-10. 被引量:6
  • 2冯柏.痰热清注射液的临床应用综述[J].中国药房,2007,18(12):944-946. 被引量:30
  • 3董卫.临床研究中常见的偏倚及其控制[J].中国实用内科杂志,2007,27(24):1985-1986. 被引量:13
  • 4刘建平.传统医学证据体的构成及证据分级的建议[J].中国中西医结合杂志,2007,27(12):1061-1065. 被引量:209
  • 5Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects [ J ]. Biometrika, 1983,70 (1) :41 -55.
  • 6Rosenbaum PR, Rubin DB. Constructing a Control Group Using Mult- ivariate Matched Sampling Methods That Incorporate the Propensity Score[ J~. American Statistician, 1985,39( 1 ) :33 - 38.
  • 7Austin PC. Some methods of propensity-score matching had superior performance to others : results of an empirical investigation and Monte Carlo simulations[ ]]. Binm J ,2009,51 ( 1 ) : 171 - 184.
  • 8Austin PC. Statistical criteria for selecting the optimal number of un- treated subjects matched to each treated subject when using many-to- one matching on the propensity score [ J ]. Am J Epidemio1,2010,172 (9) :1092 - 1097.
  • 9Park HE,Cho GY,Yoon YE,et al. Statin therapy in patients with a- typical chest and mild-to-moderate coronat~y stenosis on 64-slice rnul- tidetector coronary computed tomography; a retrospective propensity score matching analysis [ J 1. Eur Radiol, 2013, 23 ( 11 ) : 2954—2960.
  • 10Inacio MC, Chen Y, Paxton EW, et al. Statistics in Brief: An Intro- duction to the Use of Propensity Scores [ J ]. Clin Orthop Relat Res, 2015,473 ( 8 ) :2722 - 2726.

引证文献3

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部